Jubilant Pharmova Limited (JUBLPHARMA)
₹1,213.45
INR-13.65(-1.11%)
As of December 6, 2024 9:59:00 AMJubilant Pharmova Limited Share Price Information
24 hour Low and High
The lowest and highest prices reached in the last 24 hours of trading
Low: ₹1193.1
High: ₹1233.4
All time High
The highest price the stock has ever reached since being listed
₹9552.63
Price Change 1h
Price change in the last hour of trading
+₹-13.65 +-1.11%
Price Change 1d
Price change over the last trading day
+₹-13.65 +-1.11%
Price Change 1w
Price change over the last week of trading
+₹44.70 +3.82%
Jubilant Pharmova Limited Market Information
Exchange
The Exchange where the trading of the stock takes place
NSE
Market Cap
The current market capitalisation of the stock
17931.33 Cr
About Jubilant Pharmova Limited Share
Jubilant Pharmova Limited operates as an integrated pharmaceutical company in India, the Americas, Europe, and internationally. It operates through six segments: Radiopharma; Allergy Immunotherapy; Contract Development and Manufacturing Organisation - Sterile Injectables; Generics; Contract Research Development and Manufacturing Organisation; and Proprietary Novel Drugs. The Radiopharma segment offers radiopharmaceuticals products, which are used in the diagnosis and treatment of various diseases, including pulmonary embolism, cancer, coronary artery disease, and others. Its Allergy Immunotherapy segment provides specialised diagnostic devices for skin testing, as well as venom and allergy immunotherapy products. The Contract Development and Manufacturing Organisation - Sterile Injectables segment offers contract manufacturing services for sterile fill and finish injectables, liquids, ointments, creams, and ampoules. Its Generics segment engages in the development, manufacturing, distribution, sale, and marketing of generic formulations for therapeutic areas comprising cardiovascular system, central nervous system, gastrointestinal, antibiotics, and multispecialty. The Contract Research Development and Manufacturing Organisation segment offers drug discovery and development services and active pharmaceutical ingredients. The Proprietary Novel Drugs segment provides patient-focused biopharmaceutical services to address unmet medical needs in oncology and autoimmune diseases. It serves pharmaceutical, biotech, group purchasing organisations, allergists, and hospitals sectors. It sells its products through a network of dealers and distributors. The company was formerly known as Jubilant Life Sciences Limited and changed its name to Jubilant Pharmova Limited in February 2021. The company was incorporated in 1978 and is based in Noida, India.
Sector
Healthcare
Drug Manufacturers - Specialty & Generic
Employees
about
5399
CEO
Revenue (2023)
%
Country of Origin
India
Key Highlights
- Jubilant Pharmova (NSE:JUBLPHARMA) advances 8.1% this week, taking one-year gains to 157%
- Jubilant Pharmova subsidiary gets VAI classification for Washington unit from USFDA, stock hits 52-week high
- Jubilant Pharmova Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2024
- Jubilant Pharmova Limited (NSE:JUBLPHARMA) Stock Is Going Strong But Fundamentals Look Uncertain: What Lies Ahead ?
- Jubilant Pharmova Share Price Today - Jubilant Pharmova Stock Price Live NSE/BSE
Jubilant Pharmova Limited Resource
FAQs
The current price of Jubilant Pharmova Limited is INR 1213.45 — it has changed by -1.11% in the past 24 hours. Watch Jubilant Pharmova Limited's stock price performance more closely on the chart.
Jubilant Pharmova Limited has a market capitalization of 179313328128 as of today.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Jubilant Pharmova Limited's EBITDA is INR undefined
Depending on the exchange, the stock ticker may vary. For instance, on NSE exchange Jubilant Pharmova Limited stocks are traded under the ticker [object Object]
As of December 08, 2024, the company has 5399 employees.